January 12, 2024
- May 19, 2023 - NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required). See NOFO PAR-21-237.
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of an extension to PAR-21-237 “NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required". This notice of funding opportunity (NOFO) has been extended by two additional council rounds. Due to the extension, the following dates have been added: New application due date: June 9, 2024, October 9, 2024, Resubmission, Renewal due date: July 9, 2024, November 8, 2024, and AIDS application due date of September 10, 2024, January 8, 2025. The new expiration date will be January 9, 2025. All changes to the NOFO are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| June 25, 2021 | July 26, 2021 | September 07, 2021 * | November 2021 | January 2022 | April 2022 |
| October 13, 2021 | November 12, 2021 | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
| February 09, 2022 | March 09, 2022 | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
| June 09, 2022 | July 08, 2022 | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
| October 11, 2022 | November 10, 2022 | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
| February 09, 2023 | March 09, 2023 | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
| June 09, 2023 | July 10, 2023 | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
| October 10, 2023 | November 09, 2023 | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
| February 09, 2024 | March 11, 2024 | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
Expiration Date: May 8, 2024
Modified to Read:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| June 25, 2021 | July 26, 2021 | September 07, 2021 * | November 2021 | January 2022 | April 2022 |
| October 13, 2021 | November 12, 2021 | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
| February 09, 2022 | March 09, 2022 | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
| June 09, 2022 | July 08, 2022 | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
| October 11, 2022 | November 10, 2022 | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
| February 09, 2023 | March 09, 2023 | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
| June 09, 2023 | July 10, 2023 | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
| October 10, 2023 | November 09, 2023 | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
| February 09, 2024 | March 11, 2024 | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
| June 9, 2024 | July 9, 2024 | September 10, 2024 | November 2024 | January 2025 | April 2025 |
| October 9, 2024 | November 8, 2024 | January 8, 2025 | March 2025 | May 2025 | July 2025 |
Expiration Date: January 9, 2025
All other aspects of this NOFO remain unchanged.
Jeremy Brown MD
National Institute of Neurological Disorders and Stroke (NINDS)
jeremy.brown@nih.gov
OR:
National Institute of Neurological Disorders and Stroke (NINDS)
Email: Efficacy_NINDS@nih.gov
and Human Services (HHS)
